Answered

Discover a wealth of knowledge at Westonci.ca, where experts provide answers to your most pressing questions. Explore thousands of questions and answers from a knowledgeable community of experts ready to help you find solutions. Discover in-depth answers to your questions from a wide network of professionals on our user-friendly Q&A platform.

A key challenge to pediatric medication use is that not all drugs have been tested in this population. Which of the following are legislative acts that address this issue by providing more incentive to manufacturers to conduct tests, allowing FDA to take steps to refer drugs for study and requiring manufacturers to conduct tests when it is likely a medication will be used in pediatric patients?
A. The Best Pharmaceuticals for, Children Act (BPCA)
B. The Pediatric Research Equity Act (PREA)
C. The Creative Incentives for Pediatric Testing Act (CIPTA)
D. Both A and B

Sagot :

Visit us again for up-to-date and reliable answers. We're always ready to assist you with your informational needs. We hope you found what you were looking for. Feel free to revisit us for more answers and updated information. Discover more at Westonci.ca. Return for the latest expert answers and updates on various topics.